United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints
Go back to United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 493.10 -1.53 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $494.63 | 52 Week High | $164.04 | |||
| Open | $497.70 | 52 Week Low | $97.52 | |||
| Day High | $497.70 | P/E | 90.15 | |||
| Day Low | $491.26 | EPS | $5.47 | |||
| Volume | 1,185,689 | |||||
